IMMUNO-ONCOLOGY INSIGHTS

October 2020 Issue

Volume 1 Issue 1

Immuno-oncology Insights Volume 1 Issue 1

Featuring

Issue Spotlight: Clinical development strategy

SPOTLIGHT

Clinical development strategy
Jon Wigginton
Guest Editor:
Jon Wigginton, Chief Medical Officer, Cullinan Oncology

Foreword

Immuno-Oncology Insights - Spotlight on clinical development strategy

Immuno-Oncology Insights - Spotlight on clinical development strategy

Jon Wigginton
9 September 2020
Read

Expert Roundtable Video

Expert Roundtable: Clinical success of checkpoint inhibitors: what's next for combination therapy in I-O?

Expert Roundtable: Clinical success of checkpoint inhibitors: what's next for combination therapy in I-O?

J J Luke, J Fairchild , R Taylor et al.
8 October 2020
Watch

Expert Roundtable

Expert Roundtable: Clinical success of checkpoint inhibitors: what's next for combination therapy in I-O?

Expert Roundtable: Clinical success of checkpoint inhibitors: what's next for combination therapy in I-O?

J J Luke, J Fairchild , R Taylor et al.
11 November 2020
Read

Commentary

The concept of ‘iatrogenic resistance’: insights into mechanisms of induction of resistance to immune checkpoint blockade in combination immunotherapy

The concept of ‘iatrogenic resistance’: insights into mechanisms of induction of resistance to immune checkpoint blockade in combination immunotherapy

Seema Gupta, Samir Khleif
8 October 2020
Read
Cancer Immunotherapy 2020: Opportunities and Challenges on the Road Ahead

Cancer Immunotherapy 2020: Opportunities and Challenges on the Road Ahead

Fernanda Arnaldez, Jon Wigginton
8 October 2020
Read

Podcast

Analyzing current trends and future directions in I-O clinical development - Podcast

Analyzing current trends and future directions in I-O clinical development - Podcast

Daina Graybosch
8 October 2020
Listen

Interview

Finding the white space: a multi-stakeholder approach to accelerating combination drug development

Finding the white space: a multi-stakeholder approach to accelerating combination drug development

Jill O'Donnell-Tormey
18 September 2020
Read
How will the rapidly developing I-O combination therapy picture continue to evolve?

How will the rapidly developing I-O combination therapy picture continue to evolve?

Roy Baynes
16 September 2020
Read
Analyzing current trends and future directions in I-O clinical development

Analyzing current trends and future directions in I-O clinical development

Daina Graybosch
14 September 2020
Read
Leveraging advances in biological understanding to inform combination decision-making

Leveraging advances in biological understanding to inform combination decision-making

Michael Quigley
10 September 2020
Read